Yanjun Xiang

11PUBLICATIONS
35CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 17, 2026
ARID1A Stimulates Notch-TLL1 Signaling to Induce Cancer-Associated Fibroblast Activation and Intrahepatic Cholangiocarcinoma Development.

|Dec 22, 2025
Adjuvant Sintilimab with or without Anti-VEGF Therapy After Resection in Hepatocellular Carcinoma with Microvascular Invasion: A Multicenter Retrospective Study.

Kang Wang, Yan-Jun Xiang, Hong-Ming Yu

|Aug 07, 2025
PPDPF promotes the progression of esophageal squamous cell carcinoma via c-Myc/CD24 axis.

Bing Zhu, Ning Ma, Zhi-Chao Liu

|Jun 17, 2024
Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate-stage Hepatocellular Carcinoma: A Multicenter Retrospective Study.

Yitao Zheng, Yanjun Xiang, Hongqi Shi

|Jan 19, 2024
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.

Kang Wang, Yan-Jun Xiang, Hong-Ming Yu

|Dec 14, 2023
XAF1 promotes colorectal cancer metastasis via VCP-RNF114-JUP axis.

Ji Xia, Ning Ma, Qian Shi

Pageof 2

Frequent Collaborators

4 joint publications

Shuqun Cheng

4 joint publications

Jing-Jing Li

3 joint publications

Ning Ma

2 joint publications

Ji Xia